Written by Anuradha Mascarenhas, Sheriff M of Kaunain | New Delhi | Updated: November 24, 2020 7:31:52 am It comes as the UK government introduced new laws on Friday that would allow greater numbers of healthcare workers to administer flu and potential COVID-19 vaccines. (Photo: REUTERS / Archive) Oxford-AstraZeneca announced …
Read More »
The Oxford-AstraZeneca vaccine is being manufactured in partnership with the Serum Institute (Archive) New Delhi: As AstraZeneca reported Monday that its COVID-19 vaccine could be around 90% effective without serious side effects, Adar Poonawalla, whose Serum Institute is producing the injection in India, said he was “delighted.” He said the …
Read More »
Written by Anuradha Mascarenhas, edited by Explained Desk | Pune | Updated: November 21, 2020 12:04:47 pm Health worker collecting a sample during the Covid 19 test serosurvey at Darya Ganj Ramjas school on Thursday in New Delhi. Express Photo by Amit Mehra August 06, 2020 A new study in …
Read More »
The Oxford-AstraZeneca vaccine for coronavirus disease could be available to the general public between April and May next year and is likely to cost around ₹ 500-600 per dose, the executive director of the Serum Institute of India said on Thursday. , Adar Poonawalla, adding that he expects the long-awaited …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: November 20, 2020 7:08:08 am The candidate, who is being manufactured by SII under an agreement with Oxford-AstraZeneca, is the pioneer in India’s own race to find a vaccine to defeat the novel coronavirus. (Photo of Fie) Serum Institute of India …
Read More »
It was in 2011, shortly after assuming the role of CEO of the Serum Institute of India (SII), that Adar Poonawalla set out to double the capacity of what is now the world’s largest vaccine manufacturer by volume. Initially motivated by economies of scale, Poonawalla, whose father Cyrus founded the …
Read More »
As the COVID-19 The case count in India rose to more than 90 lakh on Thursday, the executive director and owner of the Pune-based Serum Institute of India, Adar Poonawalla, said the country could look forward to a vaccine against the novel coronavirus by the end of the year or …
Read More »
Children in India may have to wait a bit longer to receive their first dose of the Covid-19 vaccine when it becomes available in the country, as the deadly viral infection is less bothersome for them, the Serum Institute of India said, with headquarters in Pune. CEO and owner Adar …
Read More »
Bringing a ray of hope to a population devastated by the novel coronavirus, Pune-based Serum Institute of India CEO and owner Adar Poonawalla announced at the HT Leadership Summit 2020 on Thursday that India may well look forward to a vaccine. suitable and effective for contagious viral disease. by the …
Read More »
A year has passed since the first novel cases Coronavirus Infections were detected in the Chinese province of Wuhan. In this period, the global scientific community together with government regulators have opened new paths to develop and test vaccines against COVID-19 that can end the pandemic. These efforts have begun …
Read More »